PVLA
Palvella Therapeutics Inc

137
Mkt Cap
$837.77M
Volume
219,391.00
52W High
$83.00
52W Low
$11.17
PE Ratio
-6.01
PVLA Fundamentals
Price
$75.75
Prev Close
$75.06
Open
$74.83
50D MA
$65.15
Beta
0.91
Avg. Volume
176,415.39
EPS (Annual)
-$7.83
P/B
17.53
Rev/Employee
$0.00
Loading...
Loading...
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
14

Frequently Asked Questions

What is Market Cap of Palvella Therapeutics Inc.?
What is the 52-week high for Palvella Therapeutics Inc.?
What is the 52-week low for Palvella Therapeutics Inc.?
What is Palvella Therapeutics Inc. stock price today?
What was Palvella Therapeutics Inc. stock price yesterday?
What is the PE ratio of Palvella Therapeutics Inc.?
What is the Price-to-Book ratio of Palvella Therapeutics Inc.?
What is the 50-day moving average of Palvella Therapeutics Inc.?
How many employess does Palvella Therapeutics Inc. has?

Latest PVLA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.